Healthcare -
Biotechnology - NASDAQ - US
$ 9.8
-10.7 %
$ 32.2 M
Market Cap
-0.45
P/E
SRZN - REVENUE
Revenue SRZN - Surrozen, Inc.
10.7 M
LAST VALUE
-7.67%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR